Midi, Inc.
United StatesFDA applicant, unverified
- Devices
- 2
What Midi, Inc. makes
Midi, Inc. manufactures nucleic acid-based diagnostic systems for microbial identification, including the Sherlock Myobacteria Identification System and the Sherlock Microbial Identification System for Biodesign Evaluation (BioDEF). These devices use molecular techniques to detect and classify specific bacterial strains, supporting rapid pathogen identification in clinical and research settings.
The company’s products are regulated under FDA’s 510(k) pathway, with devices classified as Class I and Class II. The Sherlock systems are listed in the FDA’s 510(k) database, reflecting their compliance with U.S. medical device regulations. The company is headquartered in the United States.
Catalogue
Sherlock Mycobacteria Identification System Ref K020689
Regimes: 510(k) Registry: 510(k)- Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Midi, Inc. have in the registry?
The registry currently lists 2 devices for Midi, Inc.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Midi, Inc.'s devices?
Among its 2 most recently registered devices, Midi, Inc. has devices listed in FDA 510(k) (2 devices).
What risk classes do Midi, Inc.'s devices fall under?
Among its 2 most recently registered devices, the classes recorded for Midi, Inc.'s devices are Class I and Class II. Each device page shows its own class and authorisation.
What are the newest devices from Midi, Inc. in the registry?
The most recently registered devices listed for Midi, Inc. include SHERLOCK MYCOBACTERIA IDENTIFICATION SYSTEM and SHERLOCK MICROBIAL IDENTIFICATION SYSTEM FOR BIODEF.